BiomX Inc. Announces 1-for-10 Reverse Stock Split Effective Sept 9, 2026

What Happened
BiomX Inc. (PHGE) announced in an August 28, 2026 Form 8‑K that its Board, by unanimous written consent, fixed a one‑for‑ten (1‑for‑10) reverse stock split of its common stock to become effective at 12:01 a.m. Eastern Time on September 9, 2026. The split follows stockholder approval on August 25, 2026 of an amendment allowing reverse splits at ratios between 1‑for‑5 and 1‑for‑20 and reducing authorized common shares. The company expects its common stock to begin trading on the NYSE American on a split‑adjusted basis at the open on September 9, 2026.

Key Details

• Reverse split ratio: 1‑for‑10, effective 12:01 a.m. ET on Sept 9, 2026 (Certificate of Amendment to be filed with Delaware).
• Authorized shares reduced from 750,000,000 to 150,000,000 as part of the approved amendment.
• Outstanding shares to fall from ~26.7 million to ~2.7 million.
• No fractional shares will be issued; holders who would receive fractions will be rounded up to the next whole share.
• Proportionate adjustments will be made to warrants, convertible instruments and equity awards; new CUSIP for Common Stock: 09090D 608.
• Continental Stock Transfer & Trust Company will act as transfer agent and exchange agent.

Why It Matters
The reverse split reduces the number of outstanding shares and the number of authorized shares, and will change the company’s per‑share share count and CUSIP. The filing states the split will not change any stockholder’s percentage ownership except for minor effects from fractional‑share rounding, and it will trigger adjustments to warrants and convertible instruments. Investors should note the effective date (Sept 9, 2026) for split‑adjusted trading on the NYSE American and monitor confirmations from the transfer agent for any record‑level changes.